AWK vs IBRX
American Water Works (AWK) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported IBRX revenue for 2024-12-31 was $14.7M. Net income was -$413.6M. Revenue was up 2270.6% from 2023-12-31 to 2024-12-31. IBRX currently screens at market cap $7.88B.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the AWK and IBRX stock pages for the full models.
Not investment advice.